Incidence of Kidney Disease

RECENT NEWS
Motley Fool  Dec 1  Comment 
Opko Health's recently launched vitamin D prohormone could turn out to be a top seller, but only if doctors embrace it.
GenEng News  Nov 21  Comment 
Researchers from the Children's National Health System research say they have discovered a novel process by which the APOL1 gene contributes to renal disease. They reported their finding ("APOL - G1 in Nephrocytes Induces Hypertrophy and...
The Hindu Business Line  Nov 20  Comment 
Scientists are developing a functional bioartificial kidney which could replace the need for dialysis or organ transplant in the millions of patients who suffer from kidney failure. A key requireme...
MedPage Today  Nov 20  Comment 
(MedPage Today) -- Drop in development of macroalbuminuria the likely reason, researcher says
MedPage Today  Nov 18  Comment 
(MedPage Today) -- Most improvement seen in stage 3 chronic kidney disease
New York Times  Nov 10  Comment 
People with constipation had an average 13 percent higher risk of kidney disease and a 9 percent increased risk of kidney failure.
Benzinga  Sep 29  Comment 
Brean Capital assumes coverage of Akebia Therapeutics Inc (NASDAQ: AKBA) with a Buy rating, with a lowered target price of $18, citing potential success of its anemia drug. The company's lead product candidate, AKB-6548 or vadadustat is a small...
MedPage Today  Sep 28  Comment 
(MedPage Today) -- Korean study suggests some shift in risks for kidney disease patients




 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki